Russell Investments cuts Regeneron stake by 11.5%
Alpha Vantage · MarketBeat · · AI-summarised by FinFlash
Russell Investments Group Ltd. trimmed its Regeneron Pharmaceuticals stake by 11.5% in the third quarter, selling 26,384 shares and retaining 203,767 shares worth roughly Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.Understand the context